ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 033

Parental Adverse Childhood Experience (ACE) Exposure Is Predictive of Active Lupus in Pediatric Patients

Michael Nelson1, Nancy Correa 2, Ashley Butler 1, Marietta De Guzman 3, Bethanie Van Horne 1 and Christopher Greeley 1, 1Baylor College of Medicine, Houston, 2Texas Children's Hospital, Houston, 3Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Disease Activity, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Friday, May 1, 2020

Title: Poster Breakout 5 – Systemic Lupus Erythematosus

Session Type: Poster Breakout Session

Session Time: 4:30PM-5:00PM

Background/Purpose: Adverse Childhood Experiences (ACEs) have been recognized for more than two decades as risk factors for poor health outcomes in adults. Nevertheless, the impact of patient exposure to ACEs on outcomes in pediatric chronic disease has yet to be fully explored. To date, there have been no studies examining the impact of parental ACE burden on disease control in pediatric chronic disease. This study assessed parental ACE burden and disease activity in youth ages 12-17 with pediatric systemic lupus erythematosus (pSLE).

Methods: Patients were eligible for inclusion if English speaking, 12-17 years old, met ACR or SLICC classification criteria for SLE, had SLE duration of diagnosis ≥ 6 months, and had been seen in our clinic in the past year. Parents were eligible if they spoke English or Spanish. Eligible patient/parent dyads were identified on a weekly basis by reviewing the clinic schedule. Parents completed a demographic survey, CDC-Kaiser Permanente ACE questionnaire, Perceived Stress Scale (PSS), and Brief Resilient Coping Scale (BRCS). Patients were asked to complete the Morisky Medication Adherence Scale (MMAS-4), and their demographic and disease-related data were extracted from the medical record. Univariate analyses were conducted to determine associations between several variables and disease activity (SLEDAI-2K). Multivariate analysis was conducted to determine if an association existed between parental ACE burden and disease activity while controlling for several variables felt to be potential modulators of disease control.

Results: A total of 52 patient/parent dyads were enrolled in the study between May 2019 and January 2020. Patient demographics and clinical characteristics are found in Table 1 and parent demographics in Table 2. Eighteen (34%) parents reported 2 or more ACEs. Twenty-seven (52%) and 25 (48%) parents reported low and moderate-high perceived stress during the past 30 days, respectively. Sixteen (31%), 24 (47%), and 11 (22%) parents were identified as high, medium, and low resilient copers, respectively. In univariate analyses of low vs. moderate-high perceived level of stress over the past 30 days, resilient coping ability, neighborhood poverty, time since diagnosis, parent education, type of insurance (public vs. private/military), and parent primary language, none of these were found to predict active lupus (SLEDAI-2K ≥ 3) at the time of visit (Table 3). However, parental ACE burden of 2 or more was predictive of active lupus (OR = 7.7, 95% CI: 2.13-27.89). MMAS-4 was neither predictive of active disease nor was it affected by parental ACE burden. After controlling for parent reported stress over the past 30 days, insurance type, parent language, and time from diagnosis, parent reported burden of 2 or more ACEs was predictive of active lupus at the time of visit (OR = 6.9, 95% CI: 1.76-27.43).

Conclusion: Our data suggest that parental exposure to 2 or more ACEs is an important risk factor for more active disease in pediatric lupus. As such, screening for parental ACEs may be helpful in identifying youth at higher risk for active lupus. More work needs to be done to determine the manner by which parental ACE burden mediates increased lupus activity and methods to mitigate the harms.


Disclosure: M. Nelson, None; N. Correa, None; A. Butler, None; M. De Guzman, None; B. Van Horne, None; C. Greeley, None.

To cite this abstract in AMA style:

Nelson M, Correa N, Butler A, De Guzman M, Van Horne B, Greeley C. Parental Adverse Childhood Experience (ACE) Exposure Is Predictive of Active Lupus in Pediatric Patients [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/parental-adverse-childhood-experience-ace-exposure-is-predictive-of-active-lupus-in-pediatric-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/parental-adverse-childhood-experience-ace-exposure-is-predictive-of-active-lupus-in-pediatric-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology